How people with bipolar disorder use olanzapine and how education may affect weight gain
Observes how olanzapine is used in bipolar disorder, including weight gain education.
Plain-language title generated from the registry record
Registry title: A Study of Olanzapine in Participants With Bipolar Disorder.
Key facts
- Where
- Seongnam, South KoreaSee the site
Where in South Korea
- CHA Bundang Medical CenterSeongnam, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Boryung Pharmaceutical Co., Ltd
- Trial code
- NCT07263191
- Record updated
- 4 December 2025
- Original description
This study aimed to identify treatment patterns in patients with bipolar disorder receiving olanzapine according to demographic and clinical characteristics and to evaluate the effectiveness of education on weight gain, a side effect of olanzapine, in preventing weight gain.Read full original descriptionShow less
A Multicenter, Prospective Observational Study to Evaluate Treatment Patterns and Safety in Patients With Bipolar Disorder Taking Olanzapine
This study aimed to identify treatment patterns in patients with bipolar disorder receiving olanzapine according to demographic and clinical characteristics and to evaluate the effectiveness of education on weight gain, a side effect of olanzapine, in preventing weight gain.
Inclusion: Patients who have signed the informed consent after receiving information about the purpose and method of this study; Patients diagnosed with bipolar disorder and scheduled to receive olanzapine; Patients who understand the contents of the survey and can answer the questions directly.
Exclusion: Has received an investigational product within 12 weeks from the study enrollment or has plans to participate in another clinical trial during the participation of this study; Female patients who are pregnant, have childbearing potential, or are breastfeeding; Other subjects who are considered inappropriate to participate in this study by the judgment of the investigator.